Related Experiment Video
Updated: Mar 31, 2026

06:20
Author Spotlight: Developing a Unique Modular Microphysiological System to Mimic Human Barrier Tissue
Published on: February 16, 2024
1.7K
Time and architecture: the next two dimensions of microphysiological systems
Rashmi Pandey1, Jennifer Lee1, Anahita Mojiri2
1Department of Biomedical Engineering, College of Engineering, Texas A&M University, College Station, TX USA.
Summary
Physiological mimetic vascular models require better consideration of time and architecture. Incorporating longevity and design will advance complex vascular modeling for disease research and personalized medicine.
Area of Science:
- Biomedical Engineering
- Vascular Biology
- Tissue Engineering
Background:
- Microphysiological systems (MPS) are advanced in vitro models that mimic human physiology.
- Complex vasculature in MPS allows for studying cellular interactions and mechanical forces.
- Current MPS often lack sufficient consideration of temporal and architectural aspects.
Purpose of the Study:
- To review the under-explored roles of time and architecture in physiological mimetic vascular models.
- To highlight the importance of longevity and structural design in vascular modeling.
- To propose improvements for advanced vascular modeling platforms.
Main Methods:
- Comprehensive literature review focusing on time and architecture in vascular models.
- Analysis of existing microphysiological systems and their limitations.
- Synthesis of findings to propose future directions.
Main Results:
- Time (longevity) and architecture are critical but under-explored parameters in vascular modeling.
- Current models often fail to capture long-term physiological dynamics.
- Architectural complexity significantly influences model performance and relevance.
Conclusions:
- Integrating longevity and sophisticated architecture will enhance the physiological relevance of vascular models.
- Improved vascular models can support chronic disease modeling and personalized medicine.
- These advancements will provide better platforms for drug testing and tissue engineering applications.

